Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04561193 · ClinicalTrials.gov registry record
Investigation of Subsequent and Co-infections Associated With SARS-CoV-2 (COVID-19)
A clinical trial, sponsored by Methodist Health System.
- Completed
- Registry status
- 417
- Enrollment target
NCT04561193: Completed study, sponsored by Methodist Health System.
NCT04561193 is a clinical trial that has completed, run by Methodist Health System. The registered enrollment target is 417 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04561193 has completed, sponsored by Methodist Health System.
- COMPLETED
- Registry status
- 417 participants
- Enrollment target
Study Summary
Multicenter retrospective chart review of patients admitted to any of the four Methodist Health System hospitals
Primary Outcome
Prevalence of subsequent and co-infections
Interventions
- OTHER Observational
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 417 participants |
| Start Date | 2020-05-30 |
| Est. Completion | 2022-05-23 |
What the finished NCT04561193 record still lists
NCT04561193 is an observational study that tracks outcomes without assigning an intervention. The registered 417 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Observational is the first listed.
NCT04561193 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04561193 about?
NCT04561193 is a clinical study titled "Investigation of Subsequent and Co-infections Associated With SARS-CoV-2 (COVID-19)". Multicenter retrospective chart review of patients admitted to any of the four Methodist Health System hospitals
What is the current status of trial NCT04561193?
This trial is currently completed. The enrollment target is 417 participants. The study started on 2020-05-30. Estimated completion is 2022-05-23.
What interventions are being tested in trial NCT04561193?
The interventions under investigation include: Observational (OTHER).
Who is sponsoring clinical trial NCT04561193?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06169735 · 417 participants · Phase 4
Does Fluorescence With or Without Indocyanine Green Improve Parathyroid Identification and Preservation
- NCT06699901 · 417 participants
Antibiotic Concentrations After MassivE Transfusion Study
- NCT03135886 · 418 participants · NA
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
- NCT03527537 · 416 participants · Phase 4
Gestational Diabetes and Pharmacotherapy (GAP)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI